Cargando…
Small molecule targeting of the p38/Mk2 stress signaling pathways to improve cancer treatment
PURPOSE: Although a long-term goal of cancer therapy always has been the development of agents that selectively destroy cancer cells, more recent trends have been to seek secondary agents that sensitize cancer cells to existing treatment regimens. In this regard, the present study explored the possi...
Autores principales: | Alimbetov, D., Umbayev, B., Tsoy, A., Begimbetova, D., Davis, T., Kipling, D., Askarova, Sh. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517462/ https://www.ncbi.nlm.nih.gov/pubmed/37740222 http://dx.doi.org/10.1186/s12885-023-11319-x |
Ejemplares similares
-
Pharmacological Targeting of Cell Cycle, Apoptotic and Cell Adhesion Signaling Pathways Implicated in Chemoresistance of Cancer Cells
por: Alimbetov, Dauren, et al.
Publicado: (2018) -
Suppression of the senescence-associated secretory phenotype (SASP) in human fibroblasts using small molecule inhibitors of p38 MAP kinase and MK2
por: Alimbetov, Dauren, et al.
Publicado: (2015) -
Role of ROS in Aβ42 Mediated Activation of Cerebral Endothelial Cells
por: Tsoy, Andrey, et al.
Publicado: (2014) -
Ectopic Liver Tissue Formation in Rats with Induced Liver Fibrosis
por: Umbayev, Bauyrzhan, et al.
Publicado: (2014) -
Role of ROS in Aβ42 mediated cell surface P-selectin expression and actin polymerization
por: Tsoy, Andrey, et al.
Publicado: (2013)